Inicure have been granted support from VINNOVA Planeringsbidrag to improve our EIC Transition proposal. Inicure is coordinating a consortia for collaboration between LIOS, Queen Mary Hospital University London and Swansea University for a joing program to characterise and mature Inicures candidate therapies to boost the Innate immune system as novel therapy to cure resistant infections in a joint project called iCURE. The EIC Transition application will be competed and submitted in mid september 2025.
Vinnova Planeringsbidrag
AMR Conference Basel – 2026
Inicure particppated in the AMR conference i Basel meeting research collaborators, service providers and potential future commercial partners
INCATE – Network and Support
Inicure has been awarded support from the INCATE network (Incubator for Antibacterial Therapies in Europe). Access to advice and
Seal of Excellence – EIC – Transition proposal iCURE
The EIC-Transition proposal — iCURE “Novel small molecule FPR1 agonists for treating antibiotic-resistant and chronic bacterial infections” coordinated